Global Contraceptive Drugs and Devices Market Growth 2024-2030

Product Code: 795252

Industry: Pharma & Healthcare

Published: Jan 02,2024

Pages: 112

Delivery Time: 2-3 business days

Global Contraceptive Drugs and Devices Market Growth 2024-2030

Product Code: 795252

Industry: Pharma & Healthcare

Published: Jan 02,2024

Pages: 112

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to our LPI (LP Information) latest study, the global Contraceptive Drugs and Devices market size was valued at US$ 6389.6 million in 2023. With growing demand in downstream market, the Contraceptive Drugs and Devices is forecast to a readjusted size of US$ 8746.7 million by 2030 with a CAGR of 4.6% during review period. 
The research report highlights the growth potential of the global Contraceptive Drugs and Devices market. Contraceptive Drugs and Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contraceptive Drugs and Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contraceptive Drugs and Devices market.

A contraceptive is a device or drug that prevents a woman from becoming pregnant.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:
The report on Contraceptive Drugs and Devices market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Contraceptive Drugs and Devices market. It may include historical data, market segmentation by Type (e.g., Oral, Vaginal), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contraceptive Drugs and Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Contraceptive Drugs and Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Contraceptive Drugs and Devices industry. This include advancements in Contraceptive Drugs and Devices technology, Contraceptive Drugs and Devices new entrants, Contraceptive Drugs and Devices new investment, and other innovations that are shaping the future of Contraceptive Drugs and Devices.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contraceptive Drugs and Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Contraceptive Drugs and Devices product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contraceptive Drugs and Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contraceptive Drugs and Devices market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contraceptive Drugs and Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contraceptive Drugs and Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contraceptive Drugs and Devices market.

Market Segmentation:
Contraceptive Drugs and Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices

Segmentation by application
Hospitals
Pharmacies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries

Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptive Drugs and Devices market?
What factors are driving Contraceptive Drugs and Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptive Drugs and Devices market opportunities vary by end market size?
How does Contraceptive Drugs and Devices break out type, application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Contraceptive Drugs and Devices Annual Sales 2019-2030
        2.1.2 World Current & Future Analysis for Contraceptive Drugs and Devices by Geographic Region, 2019, 2023 & 2030
        2.1.3 World Current & Future Analysis for Contraceptive Drugs and Devices by Country/Region, 2019, 2023 & 2030
    2.2 Contraceptive Drugs and Devices Segment by Type
        2.2.1 Oral
        2.2.2 Vaginal
        2.2.3 Injectable Contraceptive Drugs
        2.2.4 Male/Female Contraceptive Devices
    2.3 Contraceptive Drugs and Devices Sales by Type
        2.3.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2019-2024)
        2.3.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Type (2019-2024)
        2.3.3 Global Contraceptive Drugs and Devices Sale Price by Type (2019-2024)
    2.4 Contraceptive Drugs and Devices Segment by Application
        2.4.1 Hospitals
        2.4.2 Pharmacies
        2.4.3 Others
    2.5 Contraceptive Drugs and Devices Sales by Application
        2.5.1 Global Contraceptive Drugs and Devices Sale Market Share by Application (2019-2024)
        2.5.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Application (2019-2024)
        2.5.3 Global Contraceptive Drugs and Devices Sale Price by Application (2019-2024)

3 Global Contraceptive Drugs and Devices by Company
    3.1 Global Contraceptive Drugs and Devices Breakdown Data by Company
        3.1.1 Global Contraceptive Drugs and Devices Annual Sales by Company (2019-2024)
        3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Company (2019-2024)
    3.2 Global Contraceptive Drugs and Devices Annual Revenue by Company (2019-2024)
        3.2.1 Global Contraceptive Drugs and Devices Revenue by Company (2019-2024)
        3.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Company (2019-2024)
    3.3 Global Contraceptive Drugs and Devices Sale Price by Company
    3.4 Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Contraceptive Drugs and Devices Product Location Distribution
        3.4.2 Players Contraceptive Drugs and Devices Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Contraceptive Drugs and Devices by Geographic Region
    4.1 World Historic Contraceptive Drugs and Devices Market Size by Geographic Region (2019-2024)
        4.1.1 Global Contraceptive Drugs and Devices Annual Sales by Geographic Region (2019-2024)
        4.1.2 Global Contraceptive Drugs and Devices Annual Revenue by Geographic Region (2019-2024)
    4.2 World Historic Contraceptive Drugs and Devices Market Size by Country/Region (2019-2024)
        4.2.1 Global Contraceptive Drugs and Devices Annual Sales by Country/Region (2019-2024)
        4.2.2 Global Contraceptive Drugs and Devices Annual Revenue by Country/Region (2019-2024)
    4.3 Americas Contraceptive Drugs and Devices Sales Growth
    4.4 APAC Contraceptive Drugs and Devices Sales Growth
    4.5 Europe Contraceptive Drugs and Devices Sales Growth
    4.6 Middle East & Africa Contraceptive Drugs and Devices Sales Growth

5 Americas
    5.1 Americas Contraceptive Drugs and Devices Sales by Country
        5.1.1 Americas Contraceptive Drugs and Devices Sales by Country (2019-2024)
        5.1.2 Americas Contraceptive Drugs and Devices Revenue by Country (2019-2024)
    5.2 Americas Contraceptive Drugs and Devices Sales by Type
    5.3 Americas Contraceptive Drugs and Devices Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Contraceptive Drugs and Devices Sales by Region
        6.1.1 APAC Contraceptive Drugs and Devices Sales by Region (2019-2024)
        6.1.2 APAC Contraceptive Drugs and Devices Revenue by Region (2019-2024)
    6.2 APAC Contraceptive Drugs and Devices Sales by Type
    6.3 APAC Contraceptive Drugs and Devices Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Contraceptive Drugs and Devices by Country
        7.1.1 Europe Contraceptive Drugs and Devices Sales by Country (2019-2024)
        7.1.2 Europe Contraceptive Drugs and Devices Revenue by Country (2019-2024)
    7.2 Europe Contraceptive Drugs and Devices Sales by Type
    7.3 Europe Contraceptive Drugs and Devices Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Contraceptive Drugs and Devices by Country
        8.1.1 Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2019-2024)
        8.1.2 Middle East & Africa Contraceptive Drugs and Devices Revenue by Country (2019-2024)
    8.2 Middle East & Africa Contraceptive Drugs and Devices Sales by Type
    8.3 Middle East & Africa Contraceptive Drugs and Devices Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices
    10.3 Manufacturing Process Analysis of Contraceptive Drugs and Devices
    10.4 Industry Chain Structure of Contraceptive Drugs and Devices

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Contraceptive Drugs and Devices Distributors
    11.3 Contraceptive Drugs and Devices Customer

12 World Forecast Review for Contraceptive Drugs and Devices by Geographic Region
    12.1 Global Contraceptive Drugs and Devices Market Size Forecast by Region
        12.1.1 Global Contraceptive Drugs and Devices Forecast by Region (2025-2030)
        12.1.2 Global Contraceptive Drugs and Devices Annual Revenue Forecast by Region (2025-2030)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Contraceptive Drugs and Devices Forecast by Type
    12.7 Global Contraceptive Drugs and Devices Forecast by Application

13 Key Players Analysis
    13.1 Bayer Healthcare
        13.1.1 Bayer Healthcare Company Information
        13.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.1.4 Bayer Healthcare Main Business Overview
        13.1.5 Bayer Healthcare Latest Developments
    13.2 Merck
        13.2.1 Merck Company Information
        13.2.2 Merck Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.2.4 Merck Main Business Overview
        13.2.5 Merck Latest Developments
    13.3 Church & Dwight
        13.3.1 Church & Dwight Company Information
        13.3.2 Church & Dwight Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.3.4 Church & Dwight Main Business Overview
        13.3.5 Church & Dwight Latest Developments
    13.4 Warmer Chilcott
        13.4.1 Warmer Chilcott Company Information
        13.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.4.4 Warmer Chilcott Main Business Overview
        13.4.5 Warmer Chilcott Latest Developments
    13.5 Agile Therapeutics
        13.5.1 Agile Therapeutics Company Information
        13.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.5.4 Agile Therapeutics Main Business Overview
        13.5.5 Agile Therapeutics Latest Developments
    13.6 Pfizer
        13.6.1 Pfizer Company Information
        13.6.2 Pfizer Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.6.4 Pfizer Main Business Overview
        13.6.5 Pfizer Latest Developments
    13.7 BioSante Pharmaceuticals
        13.7.1 BioSante Pharmaceuticals Company Information
        13.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.7.4 BioSante Pharmaceuticals Main Business Overview
        13.7.5 BioSante Pharmaceuticals Latest Developments
    13.8 Mayer Laboratories
        13.8.1 Mayer Laboratories Company Information
        13.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.8.4 Mayer Laboratories Main Business Overview
        13.8.5 Mayer Laboratories Latest Developments
    13.9 Pantarhei Bioscience
        13.9.1 Pantarhei Bioscience Company Information
        13.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.9.4 Pantarhei Bioscience Main Business Overview
        13.9.5 Pantarhei Bioscience Latest Developments
    13.10 Teva Pharmaceutical Industries
        13.10.1 Teva Pharmaceutical Industries Company Information
        13.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolios and Specifications
        13.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2019-2024)
        13.10.4 Teva Pharmaceutical Industries Main Business Overview
        13.10.5 Teva Pharmaceutical Industries Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Contraceptive Drugs and Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Table 2. Contraceptive Drugs and Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
    Table 3. Major Players of Oral
    Table 4. Major Players of Vaginal
    Table 5. Major Players of Injectable Contraceptive Drugs
    Table 6. Major Players of Male/Female Contraceptive Devices
    Table 7. Global Contraceptive Drugs and Devices Sales by Type (2019-2024) & (K Units)
    Table 8. Global Contraceptive Drugs and Devices Sales Market Share by Type (2019-2024)
    Table 9. Global Contraceptive Drugs and Devices Revenue by Type (2019-2024) & ($ million)
    Table 10. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2019-2024)
    Table 11. Global Contraceptive Drugs and Devices Sale Price by Type (2019-2024) & (USD/Unit)
    Table 12. Global Contraceptive Drugs and Devices Sales by Application (2019-2024) & (K Units)
    Table 13. Global Contraceptive Drugs and Devices Sales Market Share by Application (2019-2024)
    Table 14. Global Contraceptive Drugs and Devices Revenue by Application (2019-2024)
    Table 15. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2019-2024)
    Table 16. Global Contraceptive Drugs and Devices Sale Price by Application (2019-2024) & (USD/Unit)
    Table 17. Global Contraceptive Drugs and Devices Sales by Company (2019-2024) & (K Units)
    Table 18. Global Contraceptive Drugs and Devices Sales Market Share by Company (2019-2024)
    Table 19. Global Contraceptive Drugs and Devices Revenue by Company (2019-2024) ($ Millions)
    Table 20. Global Contraceptive Drugs and Devices Revenue Market Share by Company (2019-2024)
    Table 21. Global Contraceptive Drugs and Devices Sale Price by Company (2019-2024) & (USD/Unit)
    Table 22. Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution and Sales Area
    Table 23. Players Contraceptive Drugs and Devices Products Offered
    Table 24. Contraceptive Drugs and Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Contraceptive Drugs and Devices Sales by Geographic Region (2019-2024) & (K Units)
    Table 28. Global Contraceptive Drugs and Devices Sales Market Share Geographic Region (2019-2024)
    Table 29. Global Contraceptive Drugs and Devices Revenue by Geographic Region (2019-2024) & ($ millions)
    Table 30. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region (2019-2024)
    Table 31. Global Contraceptive Drugs and Devices Sales by Country/Region (2019-2024) & (K Units)
    Table 32. Global Contraceptive Drugs and Devices Sales Market Share by Country/Region (2019-2024)
    Table 33. Global Contraceptive Drugs and Devices Revenue by Country/Region (2019-2024) & ($ millions)
    Table 34. Global Contraceptive Drugs and Devices Revenue Market Share by Country/Region (2019-2024)
    Table 35. Americas Contraceptive Drugs and Devices Sales by Country (2019-2024) & (K Units)
    Table 36. Americas Contraceptive Drugs and Devices Sales Market Share by Country (2019-2024)
    Table 37. Americas Contraceptive Drugs and Devices Revenue by Country (2019-2024) & ($ Millions)
    Table 38. Americas Contraceptive Drugs and Devices Revenue Market Share by Country (2019-2024)
    Table 39. Americas Contraceptive Drugs and Devices Sales by Type (2019-2024) & (K Units)
    Table 40. Americas Contraceptive Drugs and Devices Sales by Application (2019-2024) & (K Units)
    Table 41. APAC Contraceptive Drugs and Devices Sales by Region (2019-2024) & (K Units)
    Table 42. APAC Contraceptive Drugs and Devices Sales Market Share by Region (2019-2024)
    Table 43. APAC Contraceptive Drugs and Devices Revenue by Region (2019-2024) & ($ Millions)
    Table 44. APAC Contraceptive Drugs and Devices Revenue Market Share by Region (2019-2024)
    Table 45. APAC Contraceptive Drugs and Devices Sales by Type (2019-2024) & (K Units)
    Table 46. APAC Contraceptive Drugs and Devices Sales by Application (2019-2024) & (K Units)
    Table 47. Europe Contraceptive Drugs and Devices Sales by Country (2019-2024) & (K Units)
    Table 48. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2019-2024)
    Table 49. Europe Contraceptive Drugs and Devices Revenue by Country (2019-2024) & ($ Millions)
    Table 50. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2019-2024)
    Table 51. Europe Contraceptive Drugs and Devices Sales by Type (2019-2024) & (K Units)
    Table 52. Europe Contraceptive Drugs and Devices Sales by Application (2019-2024) & (K Units)
    Table 53. Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2019-2024) & (K Units)
    Table 54. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Country (2019-2024)
    Table 55. Middle East & Africa Contraceptive Drugs and Devices Revenue by Country (2019-2024) & ($ Millions)
    Table 56. Middle East & Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2019-2024)
    Table 57. Middle East & Africa Contraceptive Drugs and Devices Sales by Type (2019-2024) & (K Units)
    Table 58. Middle East & Africa Contraceptive Drugs and Devices Sales by Application (2019-2024) & (K Units)
    Table 59. Key Market Drivers & Growth Opportunities of Contraceptive Drugs and Devices
    Table 60. Key Market Challenges & Risks of Contraceptive Drugs and Devices
    Table 61. Key Industry Trends of Contraceptive Drugs and Devices
    Table 62. Contraceptive Drugs and Devices Raw Material
    Table 63. Key Suppliers of Raw Materials
    Table 64. Contraceptive Drugs and Devices Distributors List
    Table 65. Contraceptive Drugs and Devices Customer List
    Table 66. Global Contraceptive Drugs and Devices Sales Forecast by Region (2025-2030) & (K Units)
    Table 67. Global Contraceptive Drugs and Devices Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 68. Americas Contraceptive Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
    Table 69. Americas Contraceptive Drugs and Devices Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 70. APAC Contraceptive Drugs and Devices Sales Forecast by Region (2025-2030) & (K Units)
    Table 71. APAC Contraceptive Drugs and Devices Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 72. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
    Table 73. Europe Contraceptive Drugs and Devices Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 74. Middle East & Africa Contraceptive Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
    Table 75. Middle East & Africa Contraceptive Drugs and Devices Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 76. Global Contraceptive Drugs and Devices Sales Forecast by Type (2025-2030) & (K Units)
    Table 77. Global Contraceptive Drugs and Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
    Table 78. Global Contraceptive Drugs and Devices Sales Forecast by Application (2025-2030) & (K Units)
    Table 79. Global Contraceptive Drugs and Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
    Table 80. Bayer Healthcare Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 81. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 82. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Bayer Healthcare Main Business
    Table 84. Bayer Healthcare Latest Developments
    Table 85. Merck Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 86. Merck Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 87. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Merck Main Business
    Table 89. Merck Latest Developments
    Table 90. Church & Dwight Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 91. Church & Dwight Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 92. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Church & Dwight Main Business
    Table 94. Church & Dwight Latest Developments
    Table 95. Warmer Chilcott Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 96. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 97. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Warmer Chilcott Main Business
    Table 99. Warmer Chilcott Latest Developments
    Table 100. Agile Therapeutics Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 101. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 102. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Agile Therapeutics Main Business
    Table 104. Agile Therapeutics Latest Developments
    Table 105. Pfizer Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 106. Pfizer Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 107. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Pfizer Main Business
    Table 109. Pfizer Latest Developments
    Table 110. BioSante Pharmaceuticals Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 111. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 112. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. BioSante Pharmaceuticals Main Business
    Table 114. BioSante Pharmaceuticals Latest Developments
    Table 115. Mayer Laboratories Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 116. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 117. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Mayer Laboratories Main Business
    Table 119. Mayer Laboratories Latest Developments
    Table 120. Pantarhei Bioscience Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 121. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 122. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Pantarhei Bioscience Main Business
    Table 124. Pantarhei Bioscience Latest Developments
    Table 125. Teva Pharmaceutical Industries Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
    Table 126. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolios and Specifications
    Table 127. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Teva Pharmaceutical Industries Main Business
    Table 129. Teva Pharmaceutical Industries Latest Developments
List of Figures
    Figure 1. Picture of Contraceptive Drugs and Devices
    Figure 2. Contraceptive Drugs and Devices Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Contraceptive Drugs and Devices Sales Growth Rate 2019-2030 (K Units)
    Figure 7. Global Contraceptive Drugs and Devices Revenue Growth Rate 2019-2030 ($ Millions)
    Figure 8. Contraceptive Drugs and Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
    Figure 9. Product Picture of Oral
    Figure 10. Product Picture of Vaginal
    Figure 11. Product Picture of Injectable Contraceptive Drugs
    Figure 12. Product Picture of Male/Female Contraceptive Devices
    Figure 13. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2023
    Figure 14. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2019-2024)
    Figure 15. Contraceptive Drugs and Devices Consumed in Hospitals
    Figure 16. Global Contraceptive Drugs and Devices Market: Hospitals (2019-2024) & (K Units)
    Figure 17. Contraceptive Drugs and Devices Consumed in Pharmacies
    Figure 18. Global Contraceptive Drugs and Devices Market: Pharmacies (2019-2024) & (K Units)
    Figure 19. Contraceptive Drugs and Devices Consumed in Others
    Figure 20. Global Contraceptive Drugs and Devices Market: Others (2019-2024) & (K Units)
    Figure 21. Global Contraceptive Drugs and Devices Sales Market Share by Application (2023)
    Figure 22. Global Contraceptive Drugs and Devices Revenue Market Share by Application in 2023
    Figure 23. Contraceptive Drugs and Devices Sales Market by Company in 2023 (K Units)
    Figure 24. Global Contraceptive Drugs and Devices Sales Market Share by Company in 2023
    Figure 25. Contraceptive Drugs and Devices Revenue Market by Company in 2023 ($ Million)
    Figure 26. Global Contraceptive Drugs and Devices Revenue Market Share by Company in 2023
    Figure 27. Global Contraceptive Drugs and Devices Sales Market Share by Geographic Region (2019-2024)
    Figure 28. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region in 2023
    Figure 29. Americas Contraceptive Drugs and Devices Sales 2019-2024 (K Units)
    Figure 30. Americas Contraceptive Drugs and Devices Revenue 2019-2024 ($ Millions)
    Figure 31. APAC Contraceptive Drugs and Devices Sales 2019-2024 (K Units)
    Figure 32. APAC Contraceptive Drugs and Devices Revenue 2019-2024 ($ Millions)
    Figure 33. Europe Contraceptive Drugs and Devices Sales 2019-2024 (K Units)
    Figure 34. Europe Contraceptive Drugs and Devices Revenue 2019-2024 ($ Millions)
    Figure 35. Middle East & Africa Contraceptive Drugs and Devices Sales 2019-2024 (K Units)
    Figure 36. Middle East & Africa Contraceptive Drugs and Devices Revenue 2019-2024 ($ Millions)
    Figure 37. Americas Contraceptive Drugs and Devices Sales Market Share by Country in 2023
    Figure 38. Americas Contraceptive Drugs and Devices Revenue Market Share by Country in 2023
    Figure 39. Americas Contraceptive Drugs and Devices Sales Market Share by Type (2019-2024)
    Figure 40. Americas Contraceptive Drugs and Devices Sales Market Share by Application (2019-2024)
    Figure 41. United States Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 42. Canada Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 43. Mexico Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 44. Brazil Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 45. APAC Contraceptive Drugs and Devices Sales Market Share by Region in 2023
    Figure 46. APAC Contraceptive Drugs and Devices Revenue Market Share by Regions in 2023
    Figure 47. APAC Contraceptive Drugs and Devices Sales Market Share by Type (2019-2024)
    Figure 48. APAC Contraceptive Drugs and Devices Sales Market Share by Application (2019-2024)
    Figure 49. China Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 50. Japan Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 51. South Korea Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 52. Southeast Asia Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 53. India Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 54. Australia Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 55. China Taiwan Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 56. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2023
    Figure 57. Europe Contraceptive Drugs and Devices Revenue Market Share by Country in 2023
    Figure 58. Europe Contraceptive Drugs and Devices Sales Market Share by Type (2019-2024)
    Figure 59. Europe Contraceptive Drugs and Devices Sales Market Share by Application (2019-2024)
    Figure 60. Germany Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 61. France Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 62. UK Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 63. Italy Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 64. Russia Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 65. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Country in 2023
    Figure 66. Middle East & Africa Contraceptive Drugs and Devices Revenue Market Share by Country in 2023
    Figure 67. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Type (2019-2024)
    Figure 68. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Application (2019-2024)
    Figure 69. Egypt Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 70. South Africa Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 71. Israel Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 72. Turkey Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 73. GCC Country Contraceptive Drugs and Devices Revenue Growth 2019-2024 ($ Millions)
    Figure 74. Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices in 2023
    Figure 75. Manufacturing Process Analysis of Contraceptive Drugs and Devices
    Figure 76. Industry Chain Structure of Contraceptive Drugs and Devices
    Figure 77. Channels of Distribution
    Figure 78. Global Contraceptive Drugs and Devices Sales Market Forecast by Region (2025-2030)
    Figure 79. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Region (2025-2030)
    Figure 80. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2025-2030)
    Figure 81. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Type (2025-2030)
    Figure 82. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Application (2025-2030)
    Figure 83. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Application (2025-2030)

Companies Mentioned

Bayer Healthcare

Merck

Church & Dwight

Warmer Chilcott

Agile Therapeutics

Pfizer

BioSante Pharmaceuticals

Mayer Laboratories

Pantarhei Bioscience

Teva Pharmaceutical Industries

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff